Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 375 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer				Phase IV				CZOL446GDE22 NCT00391690
	Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases				Phase IV				CZOL446EAU22 NCT00434447
	Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy				Phase IV				AVO108943 NCT00470834
	A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Proscar in Men With Initial Negative Prostate Biopsies				Phase IV				2007_029 MK0906-143, NCT00547079
	Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation				Phase IV				047838 NCT00805701
	Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia				Phase III, Phase II				001-0015-211 NCT00127387
	Androgen Suppression Alone or Combined With Zoledronate, Docetaxel, Prednisolone, and/or Celecoxib in Treating Patients With Locally Advanced or Metastatic Prostate Cancer				Phase III, Phase II				MRC-STAMPEDE EU-205102, MRC-PR08, ISRCTN78818544, EUDRACT-2004-000193-31, NCT00268476
	Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer				Phase III, Phase II				G050103 NCT00295802
	Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy				Phase III, Phase II				HEC/WST0512 66N/WST 2.21 NCT00312442
	Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo				Phase III, Phase II				AMT/P2CA/001 LC003AURON2005, NCT00332280


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute